Indian pharma companies started New Year with at least two patent infringement lawsuits filed against them in the
Second case was filed on January 13 by Takeda Pharmaceutical against Hyderabad-based generic manufacturer Aurobindo Pharma Limited (Takeda Pharmaceutical Company Limited et al v. Aurobindo Pharma Limited, New York Southern District Court, Case # 1:2010cv00247). However, we are not sure about the drug product for which patent infringement suit is filed. Readers any information on this.
Labels: Aurobindo, Duramed, LoSeasonique, Lupin, Takeda, Teva




5 Comments:
Pls do not undermine yourself by reporting such infringement updates. You have risen above this all.
Pls post more insightful and thought provoking analysis... that would minds into work. we all know you are capable of doing this.
Just a friendly advise. Don't take otherwise!
AKG
Would rather feel happy with better and larger filings by Indian companies.
Just a thought...
r u sure the second case is related to pioglitazone?
Affirmative!
Post a Comment
Subscribe to Post Comments [Atom]
<< Home